Data & Intelligence

China Data Insight (Year-End 2018)

EMPEA Members, log in and click through for your exclusive access to the detailed report and underlying data. 

Fundraising for China-focused private capital vehicles swelled to USD35 billion in 2018 despite reports of the country’s economic slowdown and ongoing trade tensions with the United States. Driven by 10 funds raising USD1 billion or more, fundraising more than doubled compared to 2017. Venture capital (VC) accounted for 42% of China’s overall fundraising total, aided by the USD2.5 billion close of Yunfeng Capital Fund III and USD1.2 billion close of Shunwei China Internet Fund IV. Technology-intensive sectors—such as software and pharmaceuticals & biotechnology—form a key part of the Made in China 2025 plan and attracted nearly USD12 billion in disclosed capital invested. Investment in software grew to USD1.8 billion, an increase of 159% from 2017. Furthermore, the pharmaceuticals & biotechnology sector attracted the majority of capital invested across all health care segments in 2018, led by CITIC Capital’s USD447 million investment in Harbin Pharmaceuticals. With Chinese government policy increasingly focused on supporting high-tech sectors, boosting domestic consumption, and addressing quality-of-life issues, GPs in China will likely continue to align their investments with these goals.


EMPEA represents the leading global investors in EM. I look forward to working alongside to drive much-needed capital for financing entrepreneurs and businesses worldwide.

Renuka Ramnath | Founder, Managing Director & Chief Executive Officer, Multiples Alternate Asset Management Private Limited

EMPEA plays an important and energetic role across the markets it represents, driving outreach and research initiatives, and promoting the role of private capital.

Brian Lim | Partner and Head of Asia and Emerging Markets, Pantheon Ventures

The developed markets have no equivalent to the role EMPEA is playing as a convener and source of trusted information in the emerging markets.

David Rubenstein | Co-Founder and Co-Executive Chairman, The Carlyle Group

I’m honored to join fellow industry pioneers in the leadership of an unparalleled network, filled with first movers, shaping the future of industries and communities.

Dr. Andrew Kuper | Founder and CEO, LeapFrog Investments

EMPEA's market and industry intelligence opens doors to new sources of capital.  I look forward to the future success of EMPEA and its members.

Torbjorn Caesar | Senior Partner, Actis

While there are certainly challenges for the industry, the opportunities abound in our target markets and globally, making a global association like EMPEA more relevant than ever.

Drew Guff | Managing Director & Founding Partner, Siguler Guff & Company